The AAOS and the Orthopaedic Research and Education Foundation (OREF) announced a strategic partnership to help narrow the gap between clinical research funding and prioritized clinical research needs in musculoskeletal care. The partnership aims to highlight areas of clinical research for which there is a need for increased, targeted funding to evaluate the effectiveness of various orthopaedic interventions and ultimately improve the quality of care for patients.
The Request for Applications (RFA) for the first research grant funded through this program will be available in November 2020 and will address injectable orthobiologics for the treatment of knee osteoarthritis.
To help jump start the effort in 2020, the AAOS is making an initial financial investment and now is the time to join in the effort to help support the investigational grants.
If you are interested in joining the fight to close clinical data gaps and improve patient care, consider a gift to the OREF/AAOS Clinical Research Gaps Fund.
"Together with our partners at OREF, we have designed a unique funding opportunity for clinical researchers looking to design and execute studies across musculoskeletal specialties beginning with orthobiologics.”
- Kristy Weber, MD, FAAOS, AAOS past president, Clinical Research Gaps Fund Leadership Team
“Funding is critical for bringing to fruition the groundbreaking and novel ideas thought leaders have throughout our specialty. The AAOS and OREF recognize this, and have developed a new funding opportunity to help researchers achieve their goals and advance the field of orthopedics.”
- Scott R. Nodzo, MD, FAAOS, Devices, Biologics and Technology Committee
“OREF is committed to supporting research that advances our field and allows us to provide optimal patient care. Likewise, the combined OREF/AAOS Clinical Research Gap Fund is meant to advance our knowledge gaps in the area of orthobiologics where there may not be clear unbiased clinical data. I hope you will consider supporting this fund."
- Arun Aneja MD PhD, Devices, Biologics and Technology Committee